C07K 14/4703
Inhibitors
Official title: {Inhibitors; Suppressors}
C07K14/4703 (Inhibitors) appears on 1,680 US grants and 2,576 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,680
- Published applications
- 2,576
- Assignees
- 1,036
- Inventors
- 4,330
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 6 | 0 |
| 1991 | 6 | 0 |
| 1992 | 16 | 0 |
| 1993 | 12 | 0 |
| 1994 | 16 | 0 |
| 1995 | 13 | 0 |
| 1996 | 28 | 0 |
| 1997 | 28 | 0 |
| 1998 | 62 | 0 |
| 1999 | 74 | 0 |
| 2000 | 51 | 0 |
| 2001 | 53 | 7 |
| 2002 | 61 | 119 |
| 2003 | 45 | 611 |
| 2004 | 41 | 114 |
| 2005 | 42 | 98 |
| 2006 | 54 | 64 |
| 2007 | 120 | 64 |
| 2008 | 98 | 65 |
| 2009 | 46 | 66 |
| 2010 | 38 | 65 |
| 2011 | 31 | 53 |
| 2012 | 36 | 50 |
| 2013 | 49 | 68 |
| 2014 | 38 | 54 |
| 2015 | 44 | 79 |
| 2016 | 50 | 93 |
| 2017 | 46 | 79 |
| 2018 | 54 | 90 |
| 2019 | 56 | 78 |
| 2020 | 50 | 100 |
| 2021 | 59 | 100 |
| 2022 | 56 | 105 |
| 2023 | 42 | 92 |
| 2024 | 59 | 100 |
| 2025 | 53 | 101 |
| 2026 | 29 | 61 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- HTT repressors comprising a zinc-finger protein transcription factor29 Sep 2026US 12,747,273 B2Sangamo Therapeutics, Inc.
- Recombinant vector comprising codon-optimized TIF1γ polynucleotide, and use thereof29 Sep 2026US 12,747,274 B2Kim, Cell & Gene Co., Ltd.
- Modulation of Wnt5a to treat glaucoma22 Sep 2026US 12,741,996 B2The Regents of the University of California
- GIPR-agonist compounds1 Sep 2026US 12,723,063 B2Eli Lilly and Company
- Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure18 Aug 2026US 12,709,738 B2The Upside Group Inc.
- Il-1ra cdnas8 Oct 2026US 2026/0308211 A1University of Florida Research Foundation, Inc.
- Cas-embedded Cytidine Deaminase Ribonucleoprotein Complexes having Improved Base Editing Specificity and Efficiency8 Oct 2026US 2026/0308553 A1University of Massachusetts
- Epigenetic targets for enhancing cancer immunotherapy1 Oct 2026US 2026/0295086 A1Duke University
- Messenger rna engineered therapeutics for treating genetic disorders (meet)1 Oct 2026US 2026/0297143 A1
- Activators of the cold stress response and uses thereof24 Sep 2026US 2026/0284050 A1Landspitali University Hospital
Most cited
By later US patents
- Pluripotent mesenchymal stem cells and methods of use thereof313US 5,827,735 AMorphoGen Pharmaceuticals, Inc. · 1998
- Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof212US 6,589,940 B1Dynavax Technologies Corporation · 2003
- Protein from urine named component B201US 5,908,827 AApplied Research Systems ARS Holding N. V. · 1999
- Proteolysis targeting chimeric pharmaceutical167US 7,041,298 B2California Institute of Technology · 2006
- Proteolysis targeting chimeric pharmaceutical161US 7,208,157 B2California Institute of Technology · 2007